INVESTIGATING THE ROLE OF A NOVEL INHIBITORY RECEPTOR COMPLEX IN DRIVING T CELL DYSFUNCTION AND THERAPEUTIC RESISTANCE TOWARD IMMUNOTHERAPIES IN LUNG CANCER.

The Cleveland Clinic Foundation

Investigators